Hiroshi Yamaji
Director
oncology
OncoTherapy Science
Japan
Biography
Hiroshi Yamaji has been serving as Director in OncoTherapy Science, Inc. since June 2005. He is holding directorship in an affiliated company and a subsidiary. He joined the Company in February 2003. His previous titles include Director of Development and Director of Business Development. He used to work in a few companies, including Sankyo Co., Ltd., Eli Lilly Japan K.K., sanofi-aventis K.K., GlaxoSmithKline, as well as Pfizer Japan Inc.
Research Interest
oncology business and development
